SOLID MALIGNANCIES
Clinical trials for SOLID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new SOLID MALIGNANCIES trials appear
Sign up with your email to follow new studies for SOLID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug CT7439 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called CT7439, alone or with other cancer treatments, in about 50 adults with solid tumors that have not responded to standard therapy. The main goal is to check safety and find the best dose. Researchers will also watch for any tumor shrin…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Carrick Therapeutics Limited • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for advanced cancers? phase 1 trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called IM-1021 in people with advanced solid tumors or lymphomas that have not responded to other treatments. The main goal is to check the drug's safety and find the best dose. About 117 adults will take part in this research.
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for advanced cancer? early trial of CMAB017 begins
Disease control Recruiting nowThis early-phase study tests a new drug called CMAB017 in about 55 people with advanced solid tumors (like head and neck, colorectal, or esophageal cancer) that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New hope for advanced cancer: first human trial of SKB571 begins
Disease control Recruiting nowThis early-stage study tests a new drug called SKB571 in 138 adults with advanced or metastatic solid tumors that have not responded to standard treatments. The main goal is to check safety and find the right dose, while also looking for signs that the drug shrinks tumors. Partic…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
New radioactive drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, 177Lu-IM-3050, in about 105 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the best dose. Participants receive the drug and are monitored for side e…
Matched conditions: SOLID MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC